niclosamide has been researched along with Cryptogenic Fibrosing Alveolitis in 2 studies
Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Niclosamide (Ncl) is an antihelminthic drug approved by FDA, which has been reported to have pleiotropic pharmacological activities in recent years, but it's almost complete insolubility in water limits its clinical application." | 1.91 | Niclosamide-loaded nanoparticles (Ncl-NPs) reverse pulmonary fibrosis in vivo and in vitro. ( Gan, C; Gong, C; Liu, H; Ouyang, L; Tan, Z; Wang, Y; Xiang, Z; Xie, Y; Yao, Y; Ye, T, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pei, X | 1 |
| Zheng, F | 1 |
| Li, Y | 1 |
| Lin, Z | 1 |
| Han, X | 1 |
| Feng, Y | 1 |
| Tian, Z | 1 |
| Ren, D | 1 |
| Cao, K | 1 |
| Li, C | 1 |
| Gan, C | 1 |
| Wang, Y | 1 |
| Xiang, Z | 1 |
| Liu, H | 1 |
| Tan, Z | 1 |
| Xie, Y | 1 |
| Yao, Y | 1 |
| Ouyang, L | 1 |
| Gong, C | 1 |
| Ye, T | 1 |
2 other studies available for niclosamide and Cryptogenic Fibrosing Alveolitis
| Article | Year |
|---|---|
Niclosamide Ethanolamine Salt Alleviates Idiopathic Pulmonary Fibrosis by Modulating the PI3K-mTORC1 Pathway.
Topics: Animals; Bleomycin; Ethanolamine; Hydroxyproline; Idiopathic Pulmonary Fibrosis; Mechanistic Target | 2022 |
Niclosamide-loaded nanoparticles (Ncl-NPs) reverse pulmonary fibrosis in vivo and in vitro.
Topics: Alveolar Epithelial Cells; Animals; Extracellular Matrix; Idiopathic Pulmonary Fibrosis; Lung Diseas | 2023 |